We are live on ! Find out more
FMI

Foundation Medicine
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

99 hedge funds and large institutions have $240M invested in Foundation Medicine in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

11% more funds holding

Funds holding: 89 → 99 (+10)

4% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 26

2.38% less ownership

Funds ownership: 35.31% → 32.93% (-2.4%)

19% less call options, than puts

Call options by funds: $9.8M | Put options by funds: $12.1M

32% less capital inflows, than outflows

Capital inflows: $27.7M | Capital outflows: $41M

Holders
99
Holders Change
+10
Holders Change %
+11.24%
% of All Funds
2.59%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
22
Increased
27
Reduced
26
Closed
11
Calls
$9.8​M
Puts
$12.1​M
Net Calls
-⁠$2.34​M
Net Calls Change
+$11.8​M

FMI Hedge Fund Activity: Q4 2015 in Review

99 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine (FMI) for Q4 2015, worth a combined $240M — up 6.7% from $224M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FMI positions and 11 closed out — a net gain of 11 holders — while 27 added to existing stakes and 26 trimmed.

The largest buyer was Michael R. Murphy, adding an estimated $6.59M. The largest seller was Bain Capital Public Equity Management, exiting entirely with an estimated $18.1M sold.

  • 99 institutional investors held Foundation Medicine (FMI) as of Q4 2015, up from 89 in Q3 2015.
  • Funds reported $240M of Foundation Medicine stock for Q4 2015, up 6.7% quarter-over-quarter.
  • 22 funds opened new Foundation Medicine positions in Q4 2015 and 11 closed out, a net change of +11 holders.
  • The largest Foundation Medicine buyer in Q4 2015 was Michael R. Murphy, an estimated $6.59M added.
  • The largest Foundation Medicine seller in Q4 2015 was Bain Capital Public Equity Management, an estimated $18.1M sold.

Based on aggregated 13F filings for Q4 2015.